Search

Your search keyword '"Shamji, Mohamed H."' showing total 733 results

Search Constraints

Start Over You searched for: Author "Shamji, Mohamed H." Remove constraint Author: "Shamji, Mohamed H."
733 results on '"Shamji, Mohamed H."'

Search Results

1. Nasal and blood transcriptomic pathways underpinning the clinical response to grass pollen immunotherapy

2. MASK-air: An OECD (Organisation for Economic Co-operation and Development) Best Practice for Public Health on Integrated Care for Chronic Diseases

3. Skin as the target for allergy prevention and treatment

4. Poor Rhinitis and Asthma Control Is Associated With Decreased Health-Related Quality of Life and Utilities: A MASK-air Study

8. Nasal allergen challenge and environmental exposure chamber challenge: A randomized trial comparing clinical and biological responses to cat allergen

9. Development and validation of an electronic daily control score for asthma (e-DASTHMA): a real-world direct patient data study

14. Nasal allergen‐neutralizing antibodies correlate closely with tolerated intranasal allergen challenge dose following grass pollen subcutaneous immunotherapy in patients with local allergic rhinitis

15. Poor rhinitis and asthma control is associated with decreased health-related quality-of-life and utilities: A MASK-air study

16. MASK-air®: An OECD (Organisation for Economic Coordination and Development) Best Practice for Public Health on integrated care for chronic diseases.

18. Dogmas, challenges, and promises in phase III allergen immunotherapy studies

19. Mechanisms of Allergy

21. The Role of Mobile Health Technologies in Stratifying Patients for AIT and Its Cessation: The ARIA-EAACI Perspective

22. Hot topics in allergen immunotherapy, 2023: Current status and future perspective

23. Allergen-specific IgG+ memory B cells are temporally linked to IgE memory responses

24. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence

26. Immunologic mechanisms of a short-course of Lolium perenne peptide immunotherapy: A randomized, double-blind, placebo-controlled trial

33. Hot topics in allergen immunotherapy, 2023: Current status and future perspective.

34. A randomized, double‐blind, placebo‐controlled trial with mannan‐conjugated birch pollen allergoids.

35. Hot topics in allergen immunotherapy, 2023: Current status and future perspective

40. Nomenclature of allergic diseases and hypersensitivity reactions: Adapted to modern needs: An EAACI position paper

43. Four years into the COVID‐19 pandemic: Timely published articles for patient care and EAACI's leadership role.

46. Standardization of clinical outcomes used in allergen immunotherapy in allergic asthma: An EAACI position paper

47. Patient‐centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA‐EAACI approach – ARIA‐EAACI Task Force Report

Catalog

Books, media, physical & digital resources